针灸或拔罐联合标准治疗中度至重度COVID-19患者:评估者盲法随机对照试验
该研究为三臂评估者盲法随机对照试验,纳入139例住院COVID-19患者,随机分为针灸组、拔罐组和对照组。结果显示,拔罐和针灸组在氧饱和度和呼吸频率改善、恢复速度及减少ICU入住或插管方面均优于对照组。结论认为拔罐和针灸是管理COVID-19的有前景的安全有效疗法。
要点
- 拔罐或针灸联合标准治疗可显著改善中度至重度COVID-19患者的氧饱和度和呼吸频率。
- 拔罐和针灸组患者恢复更快,且除针灸组2例入住ICU外,均无需ICU或插管。
- 拔罐和针灸可显著改善COVID-19相关临床症状,且安全性良好。
核心结论
- 拔罐和针灸是管理COVID-19的有前景的安全有效疗法。
研究设计与样本
- 三臂、评估者盲法、随机对照试验,共纳入139例住院COVID-19患者,随机分为针灸组、拔罐组和对照组,所有参与者均接受常规治疗。
主要发现
- 治疗3天后,拔罐组和针灸组的氧饱和度和呼吸频率较对照组显著改善,效应量分别为8.49(6.4至10.57)和8.51(6.67至10.34),p<0.001。
- 与对照组相比,拔罐组和针灸组患者恢复更快,平均差异分别为6.58(4.8至8.35)和9.16(7.16至11.15)。
- 除针灸组2例患者入住ICU外,拔罐组和针灸组均无需ICU或插管,与对照组比较p<0.001。
- 拔罐组和针灸组COVID-19相关临床症状的改善较对照组达到高度统计学显著性(p<0.01)。
临床怎么用
- 对于中度至重度COVID-19住院患者,可考虑在常规治疗基础上联合拔罐或针灸以改善呼吸症状和加快恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-pharmacological strategies that have been proposed by complementary medical systems, can be effective in management of COVID-19. METHODS: This study was designed as a three-arm, assessor-blinded, randomized controlled trial. A total of 139 hospitalized COVID-19 patients were randomly assigned into three groups: (1) acupuncture (ACUG), (2) cupping (CUPG), and (3) control (CTRG). All participants received conventional treatment. The primary study endpoint included changes in respiratory signs including oxygen saturation (SpO2) and respiratory rate (RR). The secondary endpoints were COVID-19-related hospitalization duration and serious adverse events such as intensive care unit (ICU) admission, intubation or death, all up to day 30. Also, improvements in cough, dyspnea, chest tightness, oxygen demand, anorexia, headache, weakness, sore throat, and myalgia were evaluated. RESULTS: Forty-two patients in ACUG, 44 patients in CUPG, and 42 patients in CTRG completed the trial. After 3 days, SpO2 and RR improved significantly in CUPG and ACUG compared with CTRG (effect size: 8.49 (6.4 to 10.57) and 8.51 (6.67 to 10.34), respectively: p<0.001). Compared with CTRG, patients in CUPG and ACUG recovered faster (mean difference: 6.58 (4.8 to 8.35) and 9.16 (7.16 to 11.15), respectively) and except for two patients in ACUG who were admitted to ICU, none of patients in ACUG or CUPG needed ICU or intubation (p<0.001 in comparison to CTRG). Amelioration of clinical COVID-19 related symptoms reached a high level of statistical significance in CUPG and ACUG in comparison with CTRG (p<0.01). CONCLUSION: Cupping and acupuncture are promising safe and effective therapies in management of COVID-19. Trial registration: This study was registered at Iranian Registry of Clinical Trials: IRCT20201127049504N1 (https://en.irct.ir/trial/52621).
引用
- Alipour R, Jamalimoghadamsiahkali S, Karimi M, et al. Acupuncture or cupping plus standard care versus standard care in moderate to severe COVID-19 patients: An assessor-blinded, randomized, controlled trial. Integr Med Res. 2022. PMID: 36337766. doi:10.1016/j.imr.2022.100898
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。